M

Molecure SA
WSE:MOC

Watchlist Manager
Molecure SA
WSE:MOC
Watchlist
Price: 8.6 PLN -0.69% Market Closed
Market Cap: 173.7m PLN

Wall Street
Price Targets

MOC Price Targets Summary
Molecure SA

Wall Street analysts forecast MOC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOC is 18.62 PLN with a low forecast of 16.67 PLN and a high forecast of 21 PLN.

Lowest
Price Target
16.67 PLN
94% Upside
Average
Price Target
18.62 PLN
116% Upside
Highest
Price Target
21 PLN
144% Upside
Molecure SA Competitors:
Price Targets
ZTS
Zoetis Inc
36% Upside
CRDL
Cardiol Therapeutics Inc
563% Upside
002653
Haisco Pharmaceutical Group Co Ltd
8% Upside
1477
Ocumension Therapeutics
33% Upside
NUVB
Nuvation Bio Inc
275% Upside
688506
Sichuan Biokin Pharmaceutical Co Ltd
10% Upside
VRNA
Verona Pharma PLC
26% Upside
CONCORDBIO
Concord Biotech Ltd
21% Upside

Revenue
Forecast

Revenue Estimate
Molecure SA

For the last 6 years the compound annual growth rate for Molecure SA's revenue is 145%. The projected CAGR for the next 4 years is 125%.

145%
Past Growth
125%
Estimated Growth
Estimates Accuracy
-62%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Molecure SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Molecure SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOC's stock price target?
Price Target
18.62 PLN

According to Wall Street analysts, the average 1-year price target for MOC is 18.62 PLN with a low forecast of 16.67 PLN and a high forecast of 21 PLN.

What is Molecure SA's Revenue forecast?
Projected CAGR
125%

For the last 6 years the compound annual growth rate for Molecure SA's revenue is 145%. The projected CAGR for the next 4 years is 125%.

Back to Top